The Strategy of Development of Highly Specific Antiviral Therapeutics

Dear Colleagues,

The emergence of viral diseases is expected to accelerate in recent years. These data dictate the need for active approaches to the development of widely active family-specific and cross-family therapies for use in future disease outbreaks. Advances in this area have been achieved through efforts and technical discoveries in various fields of science. The focus should be not only on the development of broad-spectrum, low-molecular-weight antivirals and direct-acting antibodies, but also on therapeutics associated with host factors, including the repurposing of previously approved or under development drugs. This Special Issue aims at the strategy of the development of highly specific antiviral therapeutics based on anti- and nanobodies, RNA, DNA, and peptide aptamers, siRNA, anti-sense oligos, and small organic molecules. Pharmaceutics is open to both original research articles and review articles focusing on the strategy of development of highly specific antiviral therapeutics. We look forward to receiving your contributions.

Prof. Dr. Tatiana B. Tennikova
Dr. Vladimir V. Sharoyko
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.